Novo Nordisk A/S ADR (NVO) Social Stream
NOVO NORDISK A S (NVO) Price Targets From Analysts
Use the tables below to see what analysts covering NOVO NORDISK A S think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 4 | $118.8 | $115 | $116.9 | $160.46 | -27.15% |
| 2022-02-09 | 4 | $118.8 | $115 | $116.9 | $160.46 | -27.15% |
| 2022-04-19 | 4 | $132.6 | $115 | $123.8 | $160.46 | -22.85% |
| 2022-04-25 | 4 | $130 | $118.8 | $124.4 | $160.46 | -22.47% |
| 2022-05-12 | 5 | $134.6 | $130 | $132.3 | $160.46 | -17.55% |
| 2022-06-16 | 5 | $134.6 | $130 | $132.3 | $160.46 | -17.55% |
| 2022-08-05 | 7 | $134.6 | $130 | $132.3 | $160.46 | -17.55% |
| 2022-12-03 | 8 | $134.6 | $130 | $132.3 | $160.46 | -17.55% |
| 2022-12-13 | 8 | $147 | $130 | $138.5 | $160.46 | -13.69% |
| 2023-02-01 | 8 | $147 | $145 | $146 | $160.46 | -9.01% |
| 2023-02-28 | 8 | $155 | $147 | $151 | $160.46 | -5.9% |
| 2023-03-01 | 8 | $174 | $155 | $164.5 | $160.46 | 2.52% |
| 2023-04-13 | 10 | $174 | $174 | $174 | $160.46 | 8.44% |
| 2023-05-10 | 10 | $195 | $174 | $184.5 | $160.46 | 14.98% |
The Trend in the Analyst Price Target
NVO's average price target has moved up $112.19 over the prior 30 months.
Over the past 47 weeks, NVO's average upside potential has been 14%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-10-03 | 8 | 134.6 | 130 | 132.3 | 102.55 | 29.01% |
| 2022-12-05 | 8 | 147.0 | 130 | 138.5 | 127.08 | 8.99% |
| 2022-12-13 | 8 | 147.0 | 145 | 146.0 | 132.84 | 9.91% |
| 2023-04-13 | 10 | 174.0 | 155 | 164.5 | 167.64 | -1.87% |
| 2023-04-17 | 10 | 195.0 | 174 | 184.5 | 171.07 | 7.85% |
NVO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.9 | 7 | 0 | 1 | 1 | 1 | 10 |
The Trend in the Broker Recommendations
Over the past 31 months, NVO's average broker recommendation rating improved by 0.41.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of stocks in the mega market cap category, NOVO NORDISK A S's variance in analysts' estimates is lower than 70.91% of them.
- To contextualize these metrics, consider that out of stocks in the mega market cap category, NOVO NORDISK A S's number of analysts covering the stock is greater than 76.03% of them.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, NOVO NORDISK A S's upside potential (average analyst target price relative to current price) is greater than 94.63% of them.
- In the context of Pharmaceutical Products stocks, NOVO NORDISK A S's average analyst price target is higher than 1353.1% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to NOVO NORDISK A S are AZN, NVS, and ABBV.
View All Top Stocks by Price Target
Make investment decisions regarding NVO using the data that counts. Try POWR Ratings for free.